Click here to read the articles and download the PDF

Pharmaceutical Commerce - October 2023

While vendors fill in gaps in products and services for the supply chain, the action moves toward new cloud-based visibility systems.

The State of the Pharma Cold Chain

The trend is continuing for brands and even for some specialty products.

Return of Cash Pay for Drugs

Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.

Counterfeit Meds: Fighting the Forgers

Articles

Ongoing clinical trials are evaluating zotatifin (eFT226) plus Faslodex (fulvestrant) and Verzenio (abemaciclib) for the treatment of ER–positive, HER2-negative advanced or metastatic breast cancer. 

Triplet Combination for Breast Cancer Gets FDA Fast Track Designation

In clinical trials, Keytruda plus Padcev lowered the risk of disease progression or death by 55% compared with chemotherapy in adult patients with locally advanced or metastatic urothelial carcinoma.

FDA Priority Review Granted to Keytruda/Padcev Combo for Locally Advanced, Metastatic Urothelial Carcinoma

Sphingosine-1-phosphate receptor modulator is designed to improve leukemia-free survival by increasing graft-versus-leukemia response.

Priothera's Mocravimod Granted to Orphan Drug Designation to Improve Post-Stem Cell Transplant Outcomes

In clinical trials, roflumilast cream demonstrated rapid and sustained improvement in the signs and symptoms of atopic dermatitis in patients 6 years of age and older.

Arcutis Biotherapeutics Seeks FDA Approval for Roflumilast in Atopic Dermatitis 

The companies will partner up to design and implement solutions that support each other's business efforts.

Cryoport, Nippon Express Establish Supply Chain Services Collaboration

In clinical trials, KarXT (xanomeline-trospium) demonstrated a combination of strong tolerability and clinically meaningful symptom reduction in adult patients with schizophrenia.

FDA to Evaluate Novel Treatment for Schizophrenia 

CDC finds administration rates for influenza antiviral medication was lower than during pre–COVID-19 pandemic flu seasons.

CDC: Lower Flu Vaccination Rates Lead to Higher Adolescent Hospitalizations in 2023-24 Season

Podcasts

Pharma Commerce editor takes a look back at 2023's impressionable editorial content. 

A Year in Review 

Biden Administration invokes Defense Production Act to facilitate domestic manufacturing of essential medicines.

White House Takes Action to Address Ongoing Drug Shortage Issue

Studies explore how both the UK and EU are handling these ongoing supply chain challenges.

Featured Content

Pharmaceutical Commerce - October 2023

The State of the Pharma Cold Chain

Return of Cash Pay for Drugs

Counterfeit Meds: Fighting the Forgers